Encorafenib (Braftovi) is an important kinase inhibitor drug used for the treatment of unresectable or metastatic melanoma, metastatic colorectal cancer, and metastatic non-small cell lung cancer with BRAF V600E or V600K mutations. As a specialized anti-cancer medication, its purchase and use must strictly comply with medical standards.

How to Purchase Encorafenib (Braftovi)

Overseas Purchase

Patients may choose to visit hospital pharmacies or legitimate drugstores in countries or regions where encorafenib has been launched to consult and purchase the drug.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan carefully before purchasing.

Purchase through Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions can usually provide legal import channels and offer professional consultation and guidance.

Precautions for Purchasing Encorafenib (Braftovi)

Prescription Review and Management

The prescription must be issued by a physician qualified in oncology diagnosis and treatment.

The prescription should include complete patient information, diagnostic basis, and medication regimen.

Physicians need to conduct a comprehensive assessment of the patient's condition.

Confirmation of Therapeutic Indications

For melanoma, detection of BRAF V600E or V600K mutations is required.

For colorectal cancer, detection of BRAF V600E mutation is required.

Mutation detection must use FDA-approved testing methods.

Identification of Dosage Form and Specification

It is available in capsule dosage form with a specification of 75 mg.

Packaging characteristics: The beige capsule cap is marked with a stylized "A", and the white capsule body is printed with "LGX 75mg".

Production information: Manufactured by Array BioPharma Inc. (a wholly-owned subsidiary of Pfizer).

Authenticity Identification of Encorafenib (Braftovi)

Identification of Anti-Counterfeiting Features on Packaging

Check if the bottle cap seal is intact.

Confirm the presence of the desiccant packet inside the bottle.

Verify key information such as batch number and expiration date.

Ensure the packaging is free from damage or deformation.

Official inquiry and verification channels.

Log on to the U.S. FDA official website to query drug approval information.

Identification of Drug Texture

The capsules should be of hard gelatin texture.

The contents are white to off-white powder.

Check the integrity of the capsules.

Risk Prevention Measures

Verify the legality of the drug source.

Refuse to purchase through informal channels.

Be alert to drugs from unknown online sources.